New COVID-19 vaccine a good value for U.S., study finds
With updated vaccines against the SARS-COV2 virus now available nationwide, a new analysis suggests that America could save money by ensuring that as many...
One in seven Americans affected by long COVID, study fidns
Long COVID, a condition that follows a COVID-19 infection and involves persistent symptoms for at least three months, has emerged as a significant concern.
Research...
Why some people have persistent long COVID symptoms
A recent study conducted by a team of researchers has explored the long-lasting physical symptoms experienced by people in Scandinavia after recovering from a...
Scientists find new hope for predicting and treating long COVID
Researchers at the University of Alberta have identified a potentially crucial amino acid that may help predict poor clinical outcomes in COVID-19 patients and...
Is it a cold, the flu or COVID-19?
This article was originally posted on October 21, 2020, and was updated on October 17, 2023.
Editor’s note: Knowledge about COVID-19 is ever-evolving. For historical...
New vaccine may shield against 3 deadly coronaviruses, study finds
A groundbreaking vaccine designed to combat three different deadly coronaviruses has shown significant promise in mouse studies, marking a substantial step forward in the...
Scientists find links between COVID-19 and Alzheimer’s disease
A review in the Journal of Neurochemistry delves into the potential connections between COVID-19 and Alzheimer's disease (AD), emphasizing the neurological symptoms experienced by...
High blood pressure and diabetes increase COVID-19 risks, study finds
Recent research reveals that individuals with uncontrolled high blood pressure and diabetes are at a higher risk of severe COVID-19 outcomes, including hospitalization, critical...
Vaccines against COVID-19, the seasonal flu and RSV are our best chance of preventing...
As cold and flu season ramps up, health care experts are once again on high alert for the possibility of a tripledemic, or a...
A new chapter in our battle against COVID-19: Omicron XBB.1.5 vaccine takes center stage
In recent times, the world has been grappling with the numerous challenges posed by the COVID-19 pandemic.
The virus, in its unrelenting manner, has morphed...